Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0.74Price to Book
VS
Market
Sector
Industry
History
$ 1.42Close
$ 1.42 - $ 4.45 52-Week Range
Ticker Information
Ticker
APRECompany Name
APREA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQAPREA THERAPEUTICS INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
APRE - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ 13.41M | $ 9.9M | 0.74 |
| 3/31/2025 | $ 15.55M | $ 8.46M | 0.54 |
| 12/31/2024 | $ 19.31M | $ 12.03M | 0.62 |
| 9/30/2024 | $ 21.95M | $ 21.63M | 0.99 |
| 6/30/2024 | $ 25.56M | $ 17.49M | 0.68 |
| 3/31/2024 | $ 28.92M | $ 31.98M | 1.11 |
| 12/31/2023 | $ 16.95M | $ 32.15M | 1.9 |
| 9/30/2023 | $ 20.29M | $ 15.13M | 0.75 |
| 6/30/2023 | $ 23.42M | $ 14.87M | 0.64 |
| 3/31/2023 | $ 26.48M | $ 13.66M | 0.52 |
Key Performance Insights, Last 5 Years
- APREA THERAPEUTICS INC's latest trailing twelve months (TTM) P/B stands at 4.86.
- Over the past 5 years, APREA THERAPEUTICS INC's average P/B has been 1.2.
- The median P/B for APREA THERAPEUTICS INC during this period was 0.77
- APREA THERAPEUTICS INC reached its highest P/B over the past 5 years at 4.86.
- The lowest P/B recorded by APREA THERAPEUTICS INC in the same timeframe 0.49
APREA THERAPEUTICS INC's P/B vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/B Benchmarks
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for APREA THERAPEUTICS INC is calculated as follows: Market Cap [ $ 432.21M ] / Equity [ $ 89.02M ]
(=) P/B [ 4.86 ] APRE - Price to Book, Last 5 years
0.49
Minimum
Mar 31, 2022
4.86
Maximum
Sep 30, 2020
1.2
Average
0.77
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.3 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.3 |
| median | 1.63 |
| std | 1.81 |